Loading clinical trials...
Loading clinical trials...
Conditions
Locations
34
United States
Neurocrine Clinical Site
Little Rock, Arkansas, United States
Neurocrine Clinical Site
Anaheim, California, United States
Neurocrine Clinical Site
Anaheim, California, United States
Neurocrine Clinical Site
Long Beach, California, United States
Neurocrine Clinical Site
Los Gatos, California, United States
Neurocrine Clinical Site
Oceanside, California, United States
Start Date
April 4, 2017
Primary Completion Date
August 1, 2018
Completion Date
August 1, 2018
Last Updated
November 22, 2017
NCT07173920
NCT06997198
NCT05859698
NCT06474650
NCT05238701
NCT02198794
Lead Sponsor
Neurocrine Biosciences
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions